Pivotal Points

Hertz Global Holdings in our Pivotal Point Check: Star Investor Bill Ackman Acquires 19.8% - Stock Soars Over 50%!

Bill Ackman's Pershing Square acquires a 19.8% stake in Hertz. Despite the positive stock reaction,...

Certara in our Pivotal Point Check: FDA to Replace Animal Testing - AI as a Gamechanger in Drug Development!

The FDA aims to replace animal testing with "human-relevant methods," including AI-based models. ...

Simply Good Foods in the Pivotal Point Check: 15.2% Revenue Increase in Q2 - Positive Forecast and Higher Price Target Boost!

In Q2, revenue increased by 15.2% to $359.7 million. The acquisition of the OWYN brand contributed...

AngloGold Ashanti in our Pivotal Point Check: the Gold Mining Company Shines Thanks to Acquisitions and Record Gold Prices!

The concern over an all-out trade dispute between the USA and China remains high. Gold continues...

UnitedHealth Group in our Pivotal Point Check: Trump Boost for Health Insurers - Forecast Increase Awaits After Doubling Medicare Payments!

After an increase of 2.23%, the payment rates for Medicare insurers will be raised by 5.06% in 2026....

W.R. Berkley in our Pivotal Point Check: new Growth Opportunities - Japanese Insurance Giant Mitsui Sumitomo Enters!

Mitsui Sumitomo Insurance plans to acquire a 15% stake in W.R. Berkley. The collaboration with...

Ulta Beauty in the Pivotal Point Check: new Strategy and "Lipstick Effect" as Growth Drivers Despite Tariffs!

The cosmetics retailer Ulta Beauty has surprisingly strong quarterly results. The new strategy...

Lamb Weston in the Pivotal Point Check: Potato Giant Impresses with Strong Q3 Figures and a Dividend Yield of 2.45%!

The frozen potato products provider has reported quarterly results exceeding expectations. The...

AngioDynamics in Pivotal Point Check: 22% Revenue Growth in Q3 - NanoKnife and Thrombectomy Drive MedTech Segment!

Strategic focus on expanding the MedTech offering leads to an impressive revenue growth of 22.2% in...

Progress Software in Pivotal Point Check: AI Focus and ShareFile Integration Drive Growth - Analysts See 30% Price Potential After Strong Q1 and Raised Guidance!

Q1 revenue increases by 29% to $238 million, earnings per share at $1.31 significantly above the forecasted...

Corcept Therapeutics in our Pivotal Point Check: Breakthrough in Cancer Research - ROSELLA Study Success Catapults Stock up Over 100%!

Ovarian cancer is the fifth leading cause of cancer-related death among women. The ROSELLA study...

Soleno Therapeutics in our Pivotal Point Check: Stifel Sees "Blockbuster Opportunity" in the FDA Approval of Vykat XR for the Treatment of Prader-Willi Syndrome!

Soleno Therapeutics has achieved a milestone in the rare disease market. The treatment with Diazoxide-Choline...

GameStop in the Pivotal Point Check: Video Game Retailer Causes a Stir With Bitcoin Entry – Bond Issuance of $1.3 Billion Weighs on Stock.

The board of GameStop has given the green light for Bitcoin as a reserve asset, which is being celebrated...

Dutch Bros in the Pivotal Point Check: 5,000 Locations Possible - Morgan Stanley Advises to Overweight the Growth-Strong Drive-Thru Coffee Chain!

In February, the drive-thru coffee chain opened its 1000th location.    Morgan Stanley...

Lumentum Holdings in the Pivotal Point Check: Key Partner for NVIDIA's AI Factories – Millions of GPUs Connected to Super Data Centers!

Lumentum is an important partner in NVIDIA's silicon photonics ecosystem to advance the scaling of...

Ollie's Bargain in the Pivotal Point Check: 75 New Stores and $300 Million Stock Buyback – RBC Sees 25% Price Potential!

Ollie's Bargain will open a total of 75 new stores in fiscal year 2025. RBC Capital Markets...

Jabil in the Pivotal Point Check: 2025 Forecast Revised Upwards - AI Demand and Humanoid Robots Boost the Contract Manufacturer!

Jabil raises its revenue forecast for 2025 from $27.3 billion to $27.9 billion.   The AI-associated...

Harrow in the Pivotal Point Check: Ophthalmology on the Rise – Q4 Revenues Nearly Doubled and Strong Forecast for 2025!

Harrow specializes in innovative ophthalmological therapies in ophthalmology. In the fourth quarter,...